These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

30 related articles for article (PubMed ID: 10399588)

  • 21. Prolactin receptor signal transduction in cells of the immune system.
    Clevenger CV; Freier DO; Kline JB
    J Endocrinol; 1998 May; 157(2):187-97. PubMed ID: 9659281
    [No Abstract]   [Full Text] [Related]  

  • 22. [Protein and polypeptide growth factors--prolactin].
    Kimura M; Kamioki S; Abe R
    Nihon Rinsho; 1986 Jan; 44(1):94-9. PubMed ID: 3007812
    [No Abstract]   [Full Text] [Related]  

  • 23. Prolactin--I (first of two parts).
    Kaul K; Dash RJ
    J Assoc Physicians India; 1980 Jul; 28(7):181-91. PubMed ID: 7009537
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of cholestasis on membrane flow and surface polarity in hepatocytes.
    Stieger B; Landmann L
    J Hepatol; 1996; 24 Suppl 1():128-34. PubMed ID: 8926364
    [No Abstract]   [Full Text] [Related]  

  • 25. [Prolactin: control of its secretion and pharmacological interference].
    Jacobelli A; Negro M; Poti C
    Clin Ter; 1980 Dec; 95(6):687-98. PubMed ID: 7011666
    [No Abstract]   [Full Text] [Related]  

  • 26. [Nuclear prolactin receptor manifestation in the rat hepatocytes and effect of prolactin].
    Orlova AN; Smirnova OV; Turovetskiĭ VB; Smirnov AN
    Biull Eksp Biol Med; 1999 May; 127(5):579-82. PubMed ID: 10399588
    [No Abstract]   [Full Text] [Related]  

  • 27. Prolactin. Physiology, pharmacology and clinical findings.
    Flückiger E; del Pozo E; von Werder K
    Monogr Endocrinol; 1982; 23():1-224. PubMed ID: 7033768
    [No Abstract]   [Full Text] [Related]  

  • 28. Interactions between prolactin and immune processes.
    Di Carlo R; Meli R
    Acta Neurol (Napoli); 1991 Aug; 13(4):380-5. PubMed ID: 1781314
    [No Abstract]   [Full Text] [Related]  

  • 29. [Mechanisms of discrimation of the prolatin physiologic action on the liver at the receptor level of hepatocytes and cholangiocytes].
    Smirnova OV; Bogorad RL
    Ross Fiziol Zh Im I M Sechenova; 2005 Feb; 91(2):184-94. PubMed ID: 15835542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Role of prolactin in experimental breast cancer. 1].
    Nagasawa H
    Horumon To Rinsho; 1971 Aug; 19(8):625-9. PubMed ID: 4938502
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.